Clinical Study

Determinants of Thyrotoxic Cardiomyopathy Recovery

Table 4

Echocardiographic parameters at enrollment and at the 6 months followup.

ParametersReferral6 months
25th percentileMedian75th percentile25th percentileMedian75th percentile

Complete reversibility
 LVEF*454850555860
 LVDD*505253434546
 LVSD*303132272728
 LVEDV*8084101768090
 LVESV*303239273031
Partial reversibility
 LVEF*354349555661
 LVDD*525456454748
 LVSD*313235272728
 LVEDV*87100.5108809499
 LVESV*3440.544303538
No reversibility
 LVEF333749324050
 LVDD545556495457
 LVSD333435303336
 LVEDV9810310790110114
 LVESV353941304045

MANOVA ANOVA .
Note: LVEF: left ventricular ejection fraction (%), LVDD: left ventricular diastolic diameter (mm), LVSD: left ventricular systolic diameter (mm), LVEDV: left ventricular end-diastolic volume (mL), *LVESV: left ventricular end-systolic volume (mL).